Antimicrobial susceptibilities of clinical Desulfovibrio isolates

被引:17
作者
Lozniewski, A
Labia, R
Haristoy, X
Mory, F
机构
[1] CHU, Bacteriol Lab, Hop Cent, F-54035 Nancy, France
[2] CNRS, UBO, MNHN, Unite FRE 2125, F-29000 Quimper, France
关键词
D O I
10.1128/AAC.45.10.2933-2935.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The antimicrobial susceptibilities of 16 clinical isolates of Desulfovibrio spp. were determined. All or most isolates were susceptible to imipenem (MIC90 [MIC at which 90% of the isolates tested were inhibited], 0.5 mug/ml), metronidazole (MIC90, 0.25 mug/ml), clindamycin (MIC90, 4 mug/ml), and chloramphenicol (MIC90, 16 mug/ml) but were resistant or intermediate to penicillin G (MIC90, 64 mug/ml), piperacillin (MIC90, 256 mug/ml), piperacillin-tazobactam (MIC90, 256 mug/ml), cefoxitin (MIC90, > 256 mug/ml), and cefotetan (MIC90, 64 mug/ml). Among isolates with decreased susceptibility to beta -lactams (n = 15), only six were beta -lactamase positive and susceptible to amoxicillin-clavulanate and ticarcillin-clavulanate.
引用
收藏
页码:2933 / 2935
页数:3
相关论文
共 9 条
[1]   A STANDARD NUMBERING SCHEME FOR THE CLASS-A BETA-LACTAMASES [J].
AMBLER, RP ;
COULSON, AFW ;
FRERE, JM ;
GHUYSEN, JM ;
JORIS, B ;
FORSMAN, M ;
LEVESQUE, RC ;
TIRABY, G ;
WALEY, SG .
BIOCHEMICAL JOURNAL, 1991, 276 :269-270
[2]   EVALUATION OF 2 METHODS FOR RAPID TESTING FOR BETA-LACTAMASE PRODUCTION IN BACTEROIDES AND FUSOBACTERIUM [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (01) :47-50
[3]   Third human isolate of a Desulfovibrio sp identical to the provisionally named Desulfovibrio fairfieldensis [J].
La Scola, B ;
Raoult, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) :3076-3077
[4]   Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis [J].
Loubinoux, J ;
Mory, F ;
Pereira, IAC ;
Le Faou, AE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :931-934
[5]   First isolation of Desulfovibrio species as part of a polymicrobial infection from a brain abscess [J].
Lozniewski, A ;
Maurer, P ;
Schuhmacher, H ;
Carlier, JP ;
Mory, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (08) :602-603
[6]   Bacteremia caused by a recently described novel Desulfovibrio species [J].
McDougall, R ;
Robson, J ;
Paterson, D ;
Tee, W .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (07) :1805-1808
[7]  
National Committee for Clinical Laboratory Standard, 1997, M11A4 NCCLS
[8]  
PORSCHEN RK, 1977, J CLIN MICROBIOL, V5, P444
[9]   Probable new species of Desulfovibrio isolated from a pyogenic liver abscess [J].
Tee, W ;
DyallSmith, M ;
Woods, W ;
Eisen, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1760-1764